Venture Capital

Newly public Errington Metals launches a massive drill program, betting on overlooked gold, silver, copper, and zinc deposits in the heart of nickel country.

The Chinese pharma giant's Q1 results reveal a successful pivot to innovation, with blockbuster deals and a strategic Nasdaq listing paving its global path.

A new powerhouse residency program backed by Silicon Valley elite launches near Stanford to turn academic science into fundable healthcare companies.

New data shows Synthekine's STK-012 overcomes resistance to standard therapy, offering hope for patients with immune-cold non-small cell lung cancer.

A record-breaking medical conference reveals a major shift in medicine, as practitioners move from simply managing aging to pursuing biological age reversal.

The advanced materials firm plans a SPAC merger to scale its 'Atomic Armor' nanocoating, aiming to secure U.S. tech sovereignty in AI and defense.

As online brands battle for loyalty, a new fulfillment model emerges, combining rapid delivery with personalized unboxing and dedicated human support.

As AI demand reshapes the digital world, industry leaders will gather at the infra/STRUCTURE Summit to navigate a critical 'interlude' and redefine strategy.

Sion Power's new 500 Wh/kg lithium-metal cells promise to revolutionize drone warfare, dramatically extending flight times and boosting US supply chain security.

California's largest independent mover expands to Vista, bringing its unique athlete workforce, job creation, and a deep commitment to community support.

Hyalex Orthopaedics’ new FDA-cleared Slalom™ implant, using cartilage-mimicking tech, offers a motion-preserving alternative to joint fusion.

As millions seek alternatives to traditional sleep pills, cannabis products are taking over. A #1 ranked gummy reveals the science and trends behind the shift.

Obsidian Therapeutics will unveil pivotal Phase 2 data on OBX-115, an engineered cell therapy that may offer a safer, more potent weapon against melanoma.

Amid a surge in Canadian infrastructure and housing, Rimkus appoints key executives to lead its expansion and tackle complex climate-resilient building challenges.

DWS slashes fees on five mutual funds, promising over $2M in annual investor savings and intensifying competition in the asset management industry.

A novel staple-like device from Inovedis gains expanded FDA approval, promising faster, less invasive repairs for a vast range of orthopedic injuries.

Biotech firm Northwest Biotherapeutics is opening a private clinic to speed up cancer therapy access, a strategic move to control its supply chain.

Fueled by a massive $110M fund, Neurophos is poaching top engineers from NVIDIA and Intel to build the future of AI with light-speed chips.

A new partnership pairs AI-powered road scans with engineering expertise, helping cash-strapped towns make data-driven infrastructure decisions.

Harrington Discovery Institute opens its 2027 award call, offering millions in funding and expert support to turn academic research into life-saving medicines.